Drug ID: | NPD6140 |
Drug Name: | |
Molecular Formula: | C25H20N4O |
Canonical SMILES: | Cn1nc(c(c1)c1ccncc1)c1ccc(cc1)OCc1ccc2c(n1)cccc2 |
Standard InCHI: | InChI=1S/C25H20N4O/c1-29-16-23(18-12-14-26-15-13-18)25(28-29)20-7-10-22(11-8-20)30-17-21-9-6-19-4-2-3-5-24(19)27-21/h2-16H,17H2,1H3 |
Standard InCHIKey: | AZEXWHKOMMASPA-UHFFFAOYSA-N |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DNCL003127 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 24857794 |
ChEBI | |
CAS Number |
Molecular Weight | 392.16 |
ALogP | -0.027 |
MLogP | 3.66 |
XLogP | 5.562 |
HDA | 4 |
HBD | 0 |
Rotatable Bonds | 6 |
TPSA | 52.83 |
RO5 Violation | 1 |